Table 1.
Effect of HFHFD Feeding on Plasma Biochemistry
Biochemical plasma analysis | CD | HFHFD | P |
---|---|---|---|
AST, U/L | |||
10–15 wk | 172 (124–225) | 127 (106–166) | .423 |
20–25 wk | 107 (88–147) | 244 (199–326) | <.001 |
32 wk | 110 (76-188) | 318 (266-457) | <.001 |
ALT, U/L | |||
10–15 wk | 7 (6–13) | 6 (6–12) | .568 |
20–25 wk | 6 (6–6) | 19 (6–40) | <.001 |
32 wk | 15 (13–30) | 141 (121–191) | <.001 |
Fasted glycemia, mg/dL | |||
10–15 wk | 128 (119–149) | 188 (159–213) | <.001 |
20–25 wk | 149 (130–173) | 236 (220–255) | <.001 |
32 wk | 155 (135–172) | 197 (179–225) | .002 |
Total cholesterol, mg/dL | |||
10–15 wk | 58 (57–62) | 125 (119–129) | <.001 |
20–25 wk | 63 (55–64) | 140 (132–152) | .002 |
32 wk | 63 (61–70) | 178 (169–192) | <.001 |
LDL, mg/dL | |||
10–15 wk | 7 (4–9) | 16 (13–17) | .051 |
20–25 wk | 7 (6–8) | 24 (19–30) | <.001 |
32 wk | 6 (5–8) | 26 (22–30) | <.001 |
HDL, mg/dL | |||
10–15 wk | 48 (38–53) | 97 (84–106) | .014 |
20–25 wk | 41 (39–49) | 87 (64–133) | .035 |
32 wk | 59 (55–64) | 138 (116–154) | <.001 |
Triglycerides, mg/dL | |||
10–15 wk | 115 (91–141) | 71 (56–91) | .073 |
20–25 wk | 93 (74–129) | 54 (48–74) | .035 |
32 wk | 107 (94–120) | 67 (64–76) | .016 |
Leptin, ng/mL | |||
10–15 wk | 2 (2–2) | 77 (68–80) | .008 |
20–25 wk | 7 (6–14) | 70 (64–74) | .016 |
32 wk | 20 (12–48) | 78 (77–79) | .004 |
Adiponectin, μg/mL | |||
10–15 wk | 41 (38–43) | 70 (61–74) | .004 |
20–25 wk | 45 (43–51) | 60 (59–61) | .030 |
32 wk | 64 (49–65) | 58 (55–59) | .931 |
NOTE. Data are presented as the median (interquartile range). Statistical analysis was performed with the Mann–Whitney U test. Significant P values are in bold.
AST, aspartate aminotransferase; HDL, high-density lipoprotein cholesterol; LDL low-density lipoprotein cholesterol.